BLUE ASH THERAPEUTICS - Key Persons
Job Titles:
- Chairman in Cardiology / Chief of the Division of Cardiology
Job Titles:
- Chief Executive Officer
- Member of the BOARD
Gregory Flexter is Chief Executive Officer and Board Member of Blue Ash Therapeutics (BAT). He has 30 years of executive leadership experience in pharmaceuticals product development, clinical research, business development, general management and executive oversight of both domestic and international operations. Having joined BAT at its founding, he is responsible for the strategic formation, development, funding and growth of the company. Prior to BAT Mr. Flexter was President, CEO and Executive Board Member of Xanodyne Pharmaceuticals. Mr. Flexter served more than five years with Shire Pharmaceuticals, where he was the Executive VP and General Manager of Shire's North American operations. Previously he led the Neuroscience Division of Novartis. Mr. Flexter began his career with Marion Laboratories.
Job Titles:
- Professor of Clinical Medicine / Director, Electrocardiography Lab
Job Titles:
- Kontos Professor & Chief of Cardiology / Medical College of Virginia / Virginia Commonwealth University / Richmond, Virginia
Job Titles:
- Member of the BOARD
- Chief Operating Officer and Board Member of BAT
Kevin J. Malloy, PhD, is Chief Operating Officer and Board member of BAT, who spent 25 years with Procter and Gamble Pharmaceuticals and founded BAT in December 2008. His scientific and managerial career spans all aspects of cardiovascular drug discovery, development and management. Dr. Malloy led the Discovery Team that brought forth azimilide and was its initial Global Project Leader in early career. In › 15 years of Development he has managed more than 20 P&G Project Teams and led billion-dollar alliances in Phase II and Phase III clinical programs covering ›20,000 patient years. He is a Fellow of the American Heart Association whose academic contacts and managerial skills have earned him a leadership reputation in broad cardiovascular circles, within both the pharma industry & the academic cardiology communities.
Job Titles:
- Head, Dept of Cardiac Sciences
Job Titles:
- Professor of Pharmacology / Director, Division of Cardiology